Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial - The Breast
PDF) Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine
INFORMATION
Eurasian Chemical Communications - Articles in Press
Chemotherapy: What it is, what to expect, side effects, and outlook
PDF) Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea
Starting Chemotherapy? - An Overview - CancerConnect
Effects of therapeutic probiotics on modulation of microRNAs
Lacto Seven - Vitabalans Oy
PDF) Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities
Lactocran + Probiotics
PDF) Probiotic supplementation attenuates the aggressiveness of chemically induced colorectal tumor in rats
10 chemotherapy tips from cancer patients who've been there | MD Anderson Cancer Center
PDF) Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy
Lactocran + Probiotics
LACTO SEVEN Parimad piimhappebakterid kogu perele.
Keytruda Doubles Survival Compared to Chemotherapy Treatment of NSCLC - CancerConnect
Chemotherapy Side Effects: 18 Ways Chemo Affects You
PDF) New pharmacotherapy options for chemotherapy-induced alimentary mucositis
Effects of probiotics on chemotherapy in patients with lung cancer
Cancer Therapy _ the Independent Consumer' - Moss, Ralph W | Vitamin A | Cancer
Lacto Seven Tablets 100 Pcs - VicNic.com
Exploring the use of Mobile applications by cancer patients undergoing chemotherapy: A scoping review - ScienceDirect
PDF) Study of pattern of adverse drug reaction due to cancer chemotherapy and their management in hospitalized patient in BP Koirala Memorial Cancer Hospital
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial - The Lancet Oncology
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health
